Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences

Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences

US Patent 8586559 · Granted Nov 19, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Link loss detection2025
Utilizing machine learning to detect malicious executable files efficiently and 2024
Compositions and methods for treating human papilloma virus infections2024
Small molecule antiviral drug treatment for human papillomavirus infections2024
Utilizing Machine Learning to detect malicious executable files efficiently and 2023
Small molecule antiviral drug treatment for human papillomavirus infections2023
Low-density parity check decoding2020
Combination therapies for treatment of spinal muscular atrophy2019
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019